Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis

Hepatology

Volumn 51, Issue 6, 2010, Pages 2097-2107

  Desai, Moreshwar S ^a   Shabier, Zainuer ^a   Taylor, Michael ^a   Lam, Fong ^a   Thevananther, Sundararajah ^a   Kosters, Astrid ^a   Karpen, Saul J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,4,6 TRIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER; BILE ACID; GLYCOGEN SYNTHASE KINASE 3BETA; LITHOCHOLIC ACID; MYOSIN HEAVY CHAIN BETA; ONCOPROTEIN; PROTEIN KINASE B; RNA; TAUROCHENODEOXYCHOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIARY TRACT FIBROSIS; BRADYCARDIA; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE COURSE; DUAL ENERGY X RAY ABSORPTIOMETRY; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; ENERGY TRANSFER; ENZYME ACTIVATION; FATIGUE; FATTY ACID OXIDATION; FEEDING; GENE CONTROL; GLYCOGEN ANALYSIS; HEART; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HISTOLOGY; HYPERTROPHIC CARDIOMYOPATHY; LIVER; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QT PROLONGATION; SIGNAL TRANSDUCTION; THYMOMA; TREADMILL EXERCISE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; UPREGULATION; VIRUS ONCOGENE;

ANIMALS; BILE ACIDS AND SALTS; BILE DUCT DISEASES; CARDIOMYOPATHY, HYPERTROPHIC; DICARBETHOXYDIHYDROCOLLIDINE; DISEASE MODELS, ANIMAL; FATIGUE; FATTY ACIDS; FIBROSIS; GENE EXPRESSION; GLYCOGEN; HEART; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; OXYGEN CONSUMPTION; PHENOTYPE; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, G-PROTEIN-COUPLED; RESPIRATORY FUNCTION TESTS; SIGNAL TRANSDUCTION;

EID: 77952728945     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23585     Document Type: Article

References (56)

1. Gaskari SA, Honar H, Lee SS. Therapy insight: cirrhotic cardiomyopathy. Nat Clin Pract Gastroenterol Hepatol 2006;3:329-337.
2. Henriksen JH, Moller S. Cardiac and systemic haemodynamic complications of liver cirrhosis. Scand Cardiovasc J 2009;43:218-225.
3. Krag A, Bendtsen F, Henriksen JH, Moller S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut 2010;59:105-110.
4. Epstein SK, Ciubotaru RL, Zilberberg MD, Kaplan LM, Jacoby C, Freeman R, et al. Analysis of impaired exercise capacity in patients with cirrhosis. Dig Dis Sci 1998;43:1701-1707. (Pubitemid 28381579)
5. Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L. The cardiac response to exercise in cirrhosis. Gut 2001;49:268-275.
6. Ceolotto G, Papparella I, Sticca A, Bova S, Cavalli M, Cargnelli G, et al. An abnormal gene expression of the beta-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats. HEPATOLOGY 2008;48:1913-1923.
7. Ma Z, Miyamoto A, Lee SS. Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats. Gastroenterology 1996;110:1191-1198. (Pubitemid 26113759)
8. Alqahtani SA, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. Semin Liver Dis 2008;28:59-69.
9. Arikan C, Kilic M, Tumgor G, Levent E, Yuksekkaya HA, Yagci RV, et al. Impact of liver transplantation on rate-corrected QT interval and myocardial function in children with chronic liver disease. Pediatr Transplant 2009;13:300-306.
10. Arnon R, Srivastava S, Fahey M, Kerkar N, Shneider BL. Hyperdynamic circulation in infants with biliary atresia and portal hypertension. HEPATOLOGY 2007;46:720A.
11. Taegtmeyer H. Switching metabolic genes to build a better heart. Circulation 2002;106:2043-2045. (Pubitemid 35192807)
12. Taha M, Lopaschuk GD. Alterations in energy metabolism in cardiomyopathies 21. Ann Med 2007;39:594-607.
13. Fukazawa K, Gologorsky E, Manmohansingh V, Nishida S, Vigoda MM, Pretto EA, Jr. Is the immediate reversal of diastolic dysfunction of cirrhotic cardiomyopathy after liver transplantation a sign of the metabolic etiology? Liver Transpl 2009;15:1417-1419.
14. Fickert P, Stoger U, Fuchsbichler A, Moustafa T, Marschall HU, Weiglein AH, et al. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol 2007;171:525-536. (Pubitemid 47344685)
15. Yang Z, Bowles NE, Scherer SE, Taylor MD, Kearney DL, Ge S, et al. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res 2006;99:646-655. (Pubitemid 44401456)
16. Durgan DJ, Moore MW, Ha NP, Egbejimi O, Fields A, Mbawuike U, et al. Circadian rhythms in myocardial metabolism and contractile function: influence of workload and oleate. Am J Physiol Heart Circ Physiol 2007;293:H2385-H2393. (Pubitemid 47605885)
17. Ghose R, Zimmerman TL, Thevananther S, Karpen SJ. Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: a novel mechanism for reduced hepatic gene expression in inflammation. Nucl Recept 2004;2:4. (Pubitemid 40617881)
18. Vallentin A, Mochly-Rosen D. RBCK1, a protein kinase CbetaI (PKCbetaI)-interacting protein, regulates PKCbeta-dependent function. J Biol Chem 2007;282:1650-1657. (Pubitemid 47076714)
19. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006;7:589-600. (Pubitemid 44325350)
20. Hardt SE, Sadoshima J. Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ Res 2002;90:1055-1063. (Pubitemid 34627903)
21. Atkinson LL, Fischer MA, Lopaschuk GD. Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis. J Biol Chem 2002;277:29424- 29430.
22. Arad M, Seidman CE, Seidman JG. AMP-activated protein kinase in the heart: role during health and disease. Circ Res 2007;100:474-488. (Pubitemid 46673257)
23. Nabben M, Hoeks J. Mitochondrial uncoupling protein 3 and its role in cardiac- and skeletal muscle metabolism. Physiol Behav 2008;94:259-269. (Pubitemid 351615421)
24. Taegtmeyer H, Razeghi P, Young ME. Mitochondrial proteins in hypertrophy and atrophy: a transcript analysis in rat heart. Clin Exp Pharmacol Physiol 2002;29:346-350. (Pubitemid 34227072)
25. Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M, et al. A G protein-coupled receptor responsive to bile acids. J Biol Chem 2003;278:9435-9440. (Pubitemid 36800434)
26. Sato H, Macchiarulo A, Thomas C, Gioiello A, Une M, Hofmann AF, et al. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. J Med Chem 2008;51:1831-1841. (Pubitemid 351438866)
27. Nguyen A, Bouscarel B. Bile acids and signal transduction: role in glucose homeostasis. Cell Signal 2008;20:2180-2197.
28. Lunseth JH, Olmstead EG, Abboud F. A study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis. AMA Arch Intern Med 1958:102:405-413.
29. Zambruni A, Trevisani F, Caraceni P, Bernardi M. Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol 2006;44:994-1002.
30. Condorelli G, Drusco A, Stassi G, Bellacosa A, Roncarati R, Iaccarino G, et al. At induces enhanced myocardial contractility and cell size in vivo in transgenic mice 20. Proc Natl Acad Sci USA 2002;99:12333-12338.
31. Morisco C, Seta K, Hardt SE, Lee Y, Vatner SF, Sadoshima J. Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes. J Biol Chem 2001;276:28586-28597. (Pubitemid 37391574)
32. Rota M, Boni A, Urbanek K, Padin-Iruegas ME, Kajstura TJ, Fiore G, et al. Nuclear targeting of Akt enhances ventricular function and myocyte contractility. Circ Res 2005;97:1332-1341. (Pubitemid 43755191)
33. Schiekofer S, Shiojima I, Sato K, Galasso G, Oshima Y, Walsh K. Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure. Physiological Genomics 2006;27:156-170. (Pubitemid 46702029)
34. Shiojima I, Yefremashvili M, Luo Z, Kureishi Y, Takahashi A, Tao J, et al. Akt signaling mediates postnatal heart growth in response to insulin and nutritional status. J Biol Chem 2002;277:37670-37677.
35. Shiojima I,Walsh K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev 2006;20:3347-3365. (Pubitemid 44969154)
36. Xiao RP, Avdonin P, Zhou YY, Cheng H, Akhter SA, Eschenhagen T, et al. Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Circ Res 1999;84:43-52. (Pubitemid 29074879)
37. Pozzi M, Carugo S, Boari G, Pecci V, de CS, Maggiolini S, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. HEPATOLOGY 1997;26:1131-1137. (Pubitemid 27509293)
38. Lunseth JH. Cardiac hypertrophy in rats with carbon tetrachloride cirrhosis. Arch Pathol 1965;79:644-646.
39. Liu H, Ma Z, Lee SS. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology 2000;118:937-944. (Pubitemid 30243757)
40. Dorn GW. Adrenergic pathways and left ventricular remodeling. J Card Fail 2002;8(6 Suppl):S370-S373. (Pubitemid 36083086)
41. Kemi OJ, Ceci M, Wisloff U, Grimaldi S, Gallo P, Smith GL, et al. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy. J Cell Physiol 2008;214:316-321. (Pubitemid 350308987)
42. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998;93:215-228. (Pubitemid 28180855)
43. Faldt J, Wernstedt I, Fitzgerald SM, Wallenius K, Bergstrom G, Jansson JO. Reduced exercise endurance in interleukin-6-deficient mice. Endocrinology 2004;145:2680-2686. (Pubitemid 38686214)
44. Taegtmeyer H. Glycogen in the heart: an expanded view. J Mol Cell Cardiol 2004;37:7-10.
45. Arad M, Moskowitz IP, Patel VV, Ahmad F, Perez-Atayde AR, Sawyer DB, et al. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation 2003;107:2850-2856.
46. Davis MK, Weinstein DA. Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk/benefit of this procedure 2. Pediatr Transplant 2008;12:137-145.
47. Wolf CM, Arad M, Ahmad F, Sanbe A, Bernstein SA, Toka O, et al. Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations. Circulation 2008;117:144-154.
48. Fickert P, Trauner M, Fuchsbichler A, Stumptner C, Zatloukal K, Denk H. Bile acid-induced Mallory body formation in drug-primed mouse liver. Am J Pathol 2002;161:2019-2026.
49. Groen AK. The emerging role of bile acids as integrators of intermediary metabolism. J Hepatol 2006;45:337-338.
50. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 2006;126:789-799.
51. Gorelik J, Patel P, Ng'andwe C, Vodyanoy I, Diakonov I, Lab M, et al. Genes encoding bile acid, phospholipid and anion transporters are expressed in a human fetal cardiomyocyte culture. BJOG 2006;113:552-558.
52. Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, et al. Bile acids induce energy expenditure by promoting intra-cellular thyroid hormone activation. Nature 2006;439:484-489.
53. Gazawi H, Ljubuncic P, Cogan U, Hochgraff E, Ben-Shachar D, Bomzon A. The effects of bile acids on beta-adrenoceptors, fluidity, and the extent of lipid peroxidation in rat cardiac membranes. Biochem Pharmacol 2000;59:1623-1628.
54. Gorelik J, Harding SE, Shevchuk AI, Koralage D, Lab M, de SM, et al. Taurocholate induces changes in rat cardiomyocyte contraction and calcium dynamics. Clin Sci (Lond) 2002;103:191-200.
55. Inserte J, Perello A, Agullo L, Ruiz-Meana M, Schluter KD, Escalona N, et al. Left ventricular hypertrophy in rats with biliary cirrhosis. HEPATOLOGY 2003;38:589-598.
56. Liu H, Song D, Lee SS. Role of heme oxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat. Am J Physiol Gastrointest Liver Physiol 2001;280:G68-G74.